ZA822933B - Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation - Google Patents

Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation

Info

Publication number
ZA822933B
ZA822933B ZA822933A ZA822933A ZA822933B ZA 822933 B ZA822933 B ZA 822933B ZA 822933 A ZA822933 A ZA 822933A ZA 822933 A ZA822933 A ZA 822933A ZA 822933 B ZA822933 B ZA 822933B
Authority
ZA
South Africa
Prior art keywords
aminocyclopentanol
esters
acids
preparation
pharmaceutical formulation
Prior art date
Application number
ZA822933A
Other languages
English (en)
Inventor
E Collington
P Hallett
C Wallis
A Wadsworth
N Hayes
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA822933B publication Critical patent/ZA822933B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
ZA822933A 1981-04-29 1982-04-29 Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation ZA822933B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8113238 1981-04-29

Publications (1)

Publication Number Publication Date
ZA822933B true ZA822933B (en) 1983-04-27

Family

ID=10521483

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822933A ZA822933B (en) 1981-04-29 1982-04-29 Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation

Country Status (4)

Country Link
JP (1) JPS57183772A (xx)
DO (1) DOP1990004772A (xx)
GB (1) GB2097397B (xx)
ZA (1) ZA822933B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt
JPS5973576A (ja) * 1982-09-16 1984-04-25 グラクソ・グル−プ・リミテツド ピペリジニルシクロペンタノ−ルヘプテン酸塩
AU576476B2 (en) * 1982-09-16 1988-09-01 Glaxo Group Limited Piperidinylcyclopentanol heptenoic acid salt
ES526813A0 (es) * 1982-10-28 1985-04-16 Glaxo Group Ltd Un procedimiento para preparar acidos de aminociclopentano
GB8307099D0 (en) * 1983-03-15 1983-04-20 Glaxo Group Ltd Carbocyclic compounds
GB2146023B (en) * 1983-09-06 1987-03-25 Glaxo Group Ltd Aminocyclopentanes and their preparation and pharmaceutical formulation
GB8601985D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Chemical process
US4968703A (en) * 1986-08-08 1990-11-06 Glaxo Group Limited Pharmaceutical compositions for the treatment of occlusive vascular diseases
GB8715333D0 (en) * 1987-06-30 1987-08-05 Glaxo Group Ltd Process
BE1001704A3 (fr) * 1987-12-22 1990-02-13 Glaxo Group Ltd Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
GB8811311D0 (en) * 1988-05-12 1988-06-15 Glaxo Group Ltd Medicaments
GB8814725D0 (en) * 1988-06-21 1988-07-27 Glaxo Group Ltd Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536475A (en) * 1978-07-11 1980-03-14 Glaxo Group Ltd Prostanoid compound
ZA81114B (en) * 1980-01-09 1982-01-27 Glaxo Group Ltd Prostanoid compounds and their preparation and pharmaceutical formalation

Also Published As

Publication number Publication date
DOP1990004772A (es) 1996-02-02
JPS57183772A (en) 1982-11-12
JPH0352456B2 (xx) 1991-08-12
GB2097397A (en) 1982-11-03
GB2097397B (en) 1984-09-19

Similar Documents

Publication Publication Date Title
PT72951B (en) Aminocyclopentane alkanoic acids and esters and their preparation and pharmaceutical formulation
IL59628A0 (en) 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them
IL56991A0 (en) 4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
DE3064453D1 (en) Isoquinoline acetic acids and pharmaceutical compositions thereof
IL78528A0 (en) Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them
IL87800A0 (en) Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
ZA822933B (en) Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
IL65629A (en) Preparation of alpha-arylalkanoic acids and esters and salts thereof
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
IL63791A0 (en) Preparation of alpha-aryl-alkanoic acids and esters thereof
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
GB2057427B (en) Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them
PH18473A (en) Aminocyclopentane acids and esters and their preparation and pharmaceutical formulation
IL64713A0 (en) Preparation of 2,2-dimethyl-3-vinylcyclopropanecarboxylic acids and esters thereof
DE3276311D1 (en) Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
ZA814532B (en) Aminocyclopentanone amides and their preparation and pharmaceutical formulation
ZA841900B (en) Aminocyclopentane esters and their preparation and pharmaceutical formulation
NZ194241A (en) 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions
AU552612B2 (en) Preparation of acids and esters
GB2146023B (en) Aminocyclopentanes and their preparation and pharmaceutical formulation
AU553571B2 (en) Preparation of acids and esters
IL58154A0 (en) 1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them
IL66621A0 (en) Preparation of alkoxyvincaminic and alkoxyapovincaminic acid esters
KE3521A (en) 2-methoxyphenyl esters of n-substituted amino acids,their preparation and pharmaceutical use
DE3266707D1 (en) Preparation of nitroarylacetic acid esters and derivatives thereof